Clinical Trials Directory

Trials / Completed

CompletedNCT05129761

Clinical Response of Syrup Hydryllin® in Pakistani Subjects With Cough in Routine Practice

Status
Completed
Phase
Study type
Observational
Enrollment
320 (actual)
Sponsor
The Searle Company Limited Pakistan · Industry
Sex
All
Age
12 Years – 70 Years
Healthy volunteers
Not accepted

Summary

A cough is one of the most common medical complaints accounting for as many as 30 million clinical visits per year. It is the single most prevalent symptom on presentation to a physician's office. Up to 40% of these complaints result in a referral to a pulmonologist. Although, the cough is an essential defense mechanism, still, chronic cough may cause significant morbidity and substantially affect the quality of life and psychosocial wellbeing.

Detailed description

Globally, the prevalence of acute cough is 9 to 64%, whereas chronic cough is \>10% in most countries or regions, ranging from 7.2%-33%. In Pakistan, a few studies have examined chronic cough resulting from specific occupations, such as those involving brick kilns, textile work, or gem cutting. Additionally, 15.8% of subjects in a periurban area of Karachi City, Pakistan with cough lasting ≥ 2 weeks were found to have pulmonary TB. Overall, to estimate the prevalence and incidence of different coughs, there is no data available based on the local population, and the data assessing the quality of life of patients with different coughs is not available. Locally, few studies were conducted on cough syrups with a small sample size. However, no real data is available for the symptomatic management of cough about the patient's quality of life related to different coughs. The current study is designed to assess the response of different strengths of Syrup Hydryllin ( Syrup Hydryllin \& Hydryllin Sugar-Free (Diphenhydramine, Ammonium Chloride, Menthol, Aminophylline) and Syrup Hydryllin DM (Dextromethorphan \& Diphenhydramine) in the symptomatic management of cough in routine practice by physicians. The study's main objective is to assess the quality of life of the subjects suffering from the different types of cough.

Conditions

Interventions

TypeNameDescription
DRUGSyrup Hydryllin( Syrup Hydryllin \& Hydryllin Sugar-Free (Diphenhydramine, Ammonium Chloride, Menthol, Aminophylline) and Syrup Hydryllin DM (Dextromethorphan \& Diphenhydramine)

Timeline

Start date
2021-11-28
Primary completion
2023-06-01
Completion
2023-11-01
First posted
2021-11-22
Last updated
2024-03-21

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT05129761. Inclusion in this directory is not an endorsement.